AMI Cardiogenic Shock

Procedure

 

Good Outcomes in Cardiogenic Shock Are Associated With:

  • Early shock recognition1
  • Initiation of Impella® support pre-PCI
  • Less use of inotropes and vasopressors
  • Use of right heart catheterization (RHC) to optimize therapy1
  • Timely escalation of care

Unloading Pre-PCI Associated with Improved AMI Cardiogenic Shock Outcome

Right Heart Failure is Common in AMI Cardiogenic Shock and Associated with a Three-Fold Increase in Mortality

It is important to identify right heart dysfunction early and before the patient leaves the cath lab.

 

Achieving >70% AMI Cardiogenic Shock Survival: Insight from National Cardiogenic Shock Initiative (NCSI) Study

William O'Neill, MD, explains how cardiac power output (CPO) and pulmonary artery pulsatility index (PAPi) are used to drive care for patients after angioplasty.

Image of a physician using a tablet in a hospital

Abiomed Academy provides self-guided online product training for health care professionals of all experience levels and roles.

Patient Management

Learn more about measuring cardiac power output (CPO) and pulmonary artery pulsatility index (PAPi), along with other patient management topics. 

References

  1. O'Neill, W.W., TCT 2020.

NPS-1188

This information is intended for use by customers, patients, and healthcare professionals in United States only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside United States, and the information from other sites you visit may not be appropriate for use in United States.